Morepen completes its first commercial batch under an ₹825 crore CDMO mandate, advancing global manufacturing partnerships ...

Morepen Laboratories Limited has announced Rs. 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs. 50 crore, has already been completed by the company under the program ...

Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) today issued an update on its recently announced Rs. 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs. 50 ...

Morepen Laboratories today issued an update on its recently announced Rs 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs 50 crore, has already been completed by the ...

Get all latest & breaking news on Morepen Laboratories. Watch videos, top stories and articles on Morepen Laboratories at moneycontrol.com.

Morepen Laboratories Limited (NSEI:MOREPENLAB) is a small-cap stock with a market capitalization of ₹18.76B. While investors primarily focus on the growth potential and competitive landscape of the ...

Morepen Laboratories Limited has commenced commercial execution of its recently announced Rs 825 crore global Contract Development and Manufacturing Organisation (CDMO) ...

If you are looking to invest in Morepen Laboratories Limited’s (NSEI:MOREPENLAB), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of ...

New Delhi [India], Nov 9 (ANI-NewsVoir): Morepen Laboratories Ltd. entered into a tie up with Vesale Pharma International of Belgium to strengthen its position in the Rs. 1000 crore probiotic market ...